rosiglitazone has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 16 (80.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aaltonen, LA; de la Chapelle, A; Eng, C; Kum, JB; Mueller, E; Sarraf, P; Smith, WM; Spiegelman, BM; Wright, HM | 1 |
| Abe, I; Eto, K; Fujishima, M; Nakamura, Y; Ohya, Y | 1 |
| Cheung, HS; Di Battista, JA; Fahmi, H; Fernandes, JC; Martel-Pelletier, J; Pelletier, JP | 1 |
| Dransfield, I; Farrow, SN; Haslett, C; Murray, J; Rossi, AG; Ward, C | 1 |
| Frauwirth, KA; Lazar, MA; Rangwala, SM; Thompson, CB; Wang, YL | 1 |
| Chicheportiche, R; Dayer, JM; Dreyer, MG; Juge-Aubry, CE; Meier, CA | 1 |
| Greenberg, AS; Mathys, JM; Rabbi, MF; Skolnik, PR | 1 |
| Joe, EH; Jou, I; Park, EJ; Park, SY | 1 |
| Greenberg, AS; Kang, YH; Muliro, KV; Palmer, HJ; Paulson, KE; Souza, SC; Yamamoto, MT | 1 |
| Boggi, U; Bugliani, M; Del Guerra, S; Del Prato, S; Lupi, R; Marchetti, P; Marselli, L; Mosca, F | 1 |
| Koeffler, HP; Maira, G; Mangiola, A; Mastrangelo, R; Mirabella, M; Morosetti, R; Rutella, S; Servidei, T | 1 |
| Atkins, KB; Brosius, FC; Northcott, CA; Watts, SW | 1 |
| Caso, JR; García-Bueno, B; Leza, JC; Lorenzo, P; Pérez-Nievas, BG | 1 |
| Bai, X; Chen, WC; Lin, MS; Wang, YD | 1 |
| Flier, JS; Gardner, NP; Guan, HP; Kershaw, EE; Lazar, MA; Schupp, M | 1 |
| Abdel-Aleem, OS; Churi, SB; Scuderi-Porter, H; Taylor, BK; Tumber, KK | 1 |
| Cerny, L; Rehan, VK; Sakurai, R; Santos, J; Shin, E; Torday, JS; Wang, Y | 1 |
| Goren, NB; Hovsepian, E; Penas, F | 1 |
| Hindman, HB; Huxlin, KR; Jeon, KI; Kulkarni, A; Phipps, RP; Sime, PJ; Woeller, CF | 1 |
| Bogacka, I; Bogacki, M; Chojnowska, K; Kurzynska, A | 1 |
20 other study(ies) available for rosiglitazone and 9-deoxy-delta-9-prostaglandin d2
| Article | Year |
|---|---|
Loss-of-function mutations in PPAR gamma associated with human colon cancer.
Topics: Amino Acid Substitution; Binding Sites; Chromans; Colorectal Neoplasms; Dimerization; DNA-Binding Proteins; Exons; Genes, Tumor Suppressor; Humans; Hydroxyeicosatetraenoic Acids; Ligands; Linoleic Acids; Linoleic Acids, Conjugated; Mutation; Prostaglandin D2; Protein Binding; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone | 1999 |
Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.
Topics: Analysis of Variance; Animals; Barium; Calcium; Chromans; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Humans; Insulin Resistance; Ion Channels; Isoxazoles; Membrane Potentials; Muscle, Smooth, Vascular; Pioglitazone; Potassium Channels; Prostaglandin D2; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1.
Topics: Aged; Blotting, Northern; Cells, Cultured; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gene Expression; Humans; Interleukin-1; Matrix Metalloproteinase 1; Promoter Regions, Genetic; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Synovial Membrane; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic | 2002 |
Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism.
Topics: Apoptosis; Binding Sites; Caspases; Cell Death; Cells, Cultured; Dinoprost; DNA-Binding Proteins; Enzyme Activation; Eosinophils; Granulocytes; Humans; Hydrolysis; I-kappa B Proteins; Neutrophils; NF-kappa B; NF-KappaB Inhibitor alpha; Peroxisomes; Prostaglandin D2; Protein Biosynthesis; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Prostaglandin; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.
Topics: Animals; Cell Death; Cell Survival; Cells, Cultured; Humans; Hypoglycemic Agents; Interleukin-3; Lymphocyte Activation; Membrane Potentials; Mice; Mice, Inbred C57BL; Mitochondria; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Rosiglitazone; T-Lymphocytes; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Up-Regulation | 2002 |
Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line; Cell Separation; Enzyme Inhibitors; Fibrinolytic Agents; Flow Cytometry; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Ligands; Monocytes; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Sialoglycoproteins; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tretinoin; Tumor Necrosis Factor-alpha; Up-Regulation; Vitamin D | 2002 |
Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Chromans; Fenofibrate; HIV-1; Humans; Leukocytes, Mononuclear; Macrophages, Alveolar; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha; Virus Replication | 2002 |
15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Carrier Proteins; DNA-Binding Proteins; Gene Expression Regulation; Inflammation; Janus Kinase 1; Janus Kinase 2; Neuroglia; Phosphorylation; Prostaglandin D2; Protein Biosynthesis; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Rosiglitazone; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors | 2003 |
TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Blotting, Western; Butadienes; Carrier Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Fluorescent Antibody Technique; JNK Mitogen-Activated Protein Kinases; Lipolysis; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitriles; Perilipin-1; Phosphoproteins; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2003 |
Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
Topics: Adipose Tissue; Adult; Aged; Blood Glucose; Fatty Acids; Fatty Acids, Nonesterified; Female; Glucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Pancreas; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factors; Triglycerides | 2004 |
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Topics: Apoptosis; Cell Differentiation; Cell Nucleus; Cell Proliferation; Cyclooxygenase 2; G2 Phase; Gene Expression; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Isoenzymes; Membrane Proteins; Neurofilament Proteins; PPAR gamma; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured; Up-Regulation; Vimentin | 2004 |
Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries.
Topics: Animals; Aorta; Arteries; Biomarkers; Blood Pressure; Carotid Arteries; Chromans; Deoxyglucose; Desoxycorticosterone; Glucose Transporter Type 4; Hypertension; Ligands; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Smooth, Vascular; PPAR gamma; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sodium Chloride; Thiazolidinediones; Troglitazone | 2005 |
Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats.
Topics: Adenosine Triphosphate; Amino Acid Transport System X-AG; Animals; Blotting, Western; Brain Chemistry; Corticosterone; Deoxyglucose; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Hypoglycemic Agents; In Vitro Techniques; Male; PPAR gamma; Prostaglandin D2; Rats; Rats, Wistar; Restraint, Physical; Rosiglitazone; Stress, Psychological; Synaptophysin; Synaptosomes; Thiazolidinediones | 2007 |
Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Humans; Hypoglycemic Agents; Ligands; PPAR gamma; Prostaglandin D2; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2007 |
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Anilides; Animals; Carboxylic Ester Hydrolases; Cycloheximide; Dietary Fats; Dose-Response Relationship, Drug; Fluorenes; Gene Expression; Leptin; Lipase; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; PPAR gamma; Prostaglandin D2; Protein Biosynthesis; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2007 |
Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Blotting, Western; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Epoxy Compounds; Gene Expression; Injections, Intraventricular; Injections, Spinal; Male; Motor Activity; Neuralgia; PPAR gamma; Prostaglandin D2; Protein Binding; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Sciatic Nerve; Spinal Cord; Thiazolidinediones | 2008 |
Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model.
Topics: Adipose Tissue; Animals; Biomarkers; Blood Gas Analysis; Cell Differentiation; Dose-Response Relationship, Drug; Drug Administration Schedule; Epithelial Cells; Injections, Intraperitoneal; Kidney; Liver; Lung; Membrane Proteins; Mesoderm; Models, Animal; Perilipin-2; PPAR gamma; Prostaglandin D2; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Respiratory System Agents; Rosiglitazone; Thiazolidinediones; Time Factors | 2009 |
15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells.
Topics: Animals; Animals, Newborn; Blotting, Western; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Lipopolysaccharides; Matrix Metalloproteinase 9; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2010 |
Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.
Topics: Actins; Animals; Cats; Cell Line, Transformed; Cell Nucleus; Chromans; Collagen Type I; Cornea; Fibronectins; Fibrosis; Humans; Ligands; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Kinase Inhibitors; Protein Transport; Rosiglitazone; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta1; Troglitazone; Wound Healing | 2014 |
Peroxisome proliferator activated receptor ligands affect progesterone and 17β-estradiol secretion by porcine corpus luteum during early pregnancy.
Topics: 3-Hydroxysteroid Dehydrogenases; Anilides; Animals; Benzamides; Corpus Luteum; Estradiol; Estrous Cycle; Female; Gene Expression; Indoles; Ligands; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Pregnancy; Progesterone; Prostaglandin D2; Pyridines; Pyrimidines; RNA, Messenger; Rosiglitazone; Swine; Thiazolidinediones | 2014 |